Randomized Controlled Double Blind Trial

Title Average Ratingsort ascending
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis. 100.00%
Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamid 100.00%
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. 95.00%
Ukrain (NSC-631570) in the treatment of pancreas cancer. 95.00%
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial. 90.00%
Hibiscus sabdariffa L. Tea (Tisane) Lowers Blood Pressure in Prehypertensive and Mildly Hypertensive Adults 90.00%
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor acti 90.00%
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer. 70.00%
Reduced cannabis use after low-dose naltrexone addition to opioid detoxification. 70.00%
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal ca. patients 70.00%
Controlled clinical evaluations of chlorine dioxide, chlorite and chlorate in man. 70.00%
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial 70.00%
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer 50.00%
Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine 10.00%